Risuteganib for the treatment of DME

August 16, 2018

Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research  in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.

Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research  in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.